1.Early Cancer of the Gastric Stump after Gastrojejunostomy for Duodenal Ulcer Obstruction.
Hyun Kwang CHOO ; Kyeong Soo KIM ; Jeong Seop MOON ; Yoon Tae JEEN ; Ho Sang RYU ; Jin Hai HYUN
Korean Journal of Gastrointestinal Endoscopy 1990;10(2):331-335
Cancer of the gastric stump, first described by Balfour in 1922, is defined as the cancer detected more than 5 years after surgery for a benign disease. We experienced a case of cancer found at the gastric stump after gastrojejunostomy in a 53 years old male patients, proven pathologically as a early cancer. He visited to our hospital with the chief complaint of epigastric pain and indigestion for 1 Months. On past history, he has been received gastrojejunostomy due to duodenal ulcer obstruction, 23 years ago, Gastrofiberscopy was done, and we could find the early gastric cancer lesions at the anterior wall of gastric angle as type Ilc+III and antrum as type IIa. The microscopic finding of the multiple endoscopic biopsies at the gastic angle and antrum revealed the adenocarcinoma of signet ring cell type infiltrated to the level of submucosa. And so, we could diagnose these lesions as a early gastric cancer in the gastric stump after gastrojejunostomy. He was treated with subtotal gastrectomy and discharged with cured condition. Therefore, we report this case with a literature review.
Adenocarcinoma
;
Biopsy
;
Duodenal Ulcer*
;
Dyspepsia
;
Gastrectomy
;
Gastric Bypass*
;
Gastric Stump*
;
Humans
;
Male
;
Middle Aged
;
Stomach Neoplasms
3.Intrathyroidal Metastasis of Lung Adenocarcinoma Presenting as Subacute Thyroiditis.
Hyun Sung SHIN ; Young Kwang CHOO ; Won Ae LEE ; Hyun Kyung CHUNG
Endocrinology and Metabolism 2010;25(3):226-230
One of the rare diseases for differential diagnosis of subacute thyroiditis is metastases within the thyroid gland. We report here on a 72-year-old-woman with painful goiter and signs of hyperthyroidism. Her serum concentration of thyroid hormone was in the upper limit of normal, and the uptake of radioactive iodine by the thyroid was completely depressed. Although subacute thyroiditis was suspected, an additional work up that included a chest CT scan was done for the combined cough and chronic weakness. The result was lung cancer with metastatic involvement of the thyroid and multiple lymph nodes. She refused further anti-cancer therapy and died 5 months after the diagnosis. For the differential diagnosis of such a rare case, careful examination is important even in patients with the typical symptoms and laboratory findings of subacute thyroiditis.
Adenocarcinoma
;
Cough
;
Diagnosis, Differential
;
Goiter
;
Humans
;
Hyperthyroidism
;
Iodine
;
Lung
;
Lung Neoplasms
;
Lymph Nodes
;
Neoplasm Metastasis
;
Rare Diseases
;
Thorax
;
Thyroid Gland
;
Thyroiditis, Subacute
4.Primary Lymphoma of the Spleen: A case report.
Kwang Hyun KIM ; Chol Kyoon CHO ; Sang Woo CHOO ; Hyun Jong KIM ; Kyung Soo KIM
Journal of the Korean Surgical Society 1997;52(6):912-917
Primary lymphoma of the spleen is a relatively rare disease entity and is usually defined, although it is still controversial and hard to define, as the lymphoma which involved primarily the spleen and splenic hilar lymph nodes without involvement in any other site, particularly in the liver and in the mesenteric or para-aortic lymph nodes. In laparotomy of patients with non-Hodgkin's lymphoma, splenic involvements are found in 30 to 50% of patients as part of a diffuse pattern of the disease, but primary lymphoma of the spleen accounts for less than 1 % of all lymphoma cases. And it is often difficult to determine during laparotomy whether splenic involvement with lymphoma is primary or the result of a spread from another site. We herein report on a case of primary lymphoma of the spleen which was detected incidentally during evaluation of the cause of right upper quadrant abdominal pain. During the operation, a splenic tumor was found without the evidence of involvement in other sites, and it was confirmed pathologically to be a non-Hodgkin's lymphoma of the spleen. She lives well now without evidence of recurrence 14 months after the operation.
Abdominal Pain
;
Humans
;
Laparotomy
;
Liver
;
Lymph Nodes
;
Lymphoma*
;
Lymphoma, Non-Hodgkin
;
Rare Diseases
;
Recurrence
;
Spleen*
5.Portal Vein Stenting for Delayed Jejunal Varix Bleeding Associated with Portal Venous Occlusion after Hepatobiliary and Pancreatic Surgery.
Dongho HYUN ; Kwang Bo PARK ; Sung Ki CHO ; Hong Suk PARK ; Sung Wook SHIN ; Sung Wook CHOO ; Young Soo DO ; In Wook CHOO ; Dong Wook CHOI
Korean Journal of Radiology 2017;18(5):828-834
OBJECTIVE: The study aimed to describe portal stenting for postoperative portal occlusion with delayed (≥ 3 months) variceal bleeding in the afferent jejunal loop. MATERIALS AND METHODS: Eleven consecutive patients (age range, 2–79 years; eight men and three women) who underwent portal stenting between April 2009 and December 2015 were included in the study. Preoperative medical history and the postoperative clinical course were reviewed. Characteristics of portal occlusion and details of procedures were also investigated. Technical success, treatment efficacy (defined as disappearance of jejunal varix on follow-up CT), and clinical success were analyzed. Primary stent patency rate was plotted using the Kaplan-Meier method. RESULTS: All patients underwent hepatobiliary-pancreatic cancer surgery except two children with liver transplantation for biliary atresia. Portal occlusion was caused by benign postoperative change (n = 6) and local tumor recurrence (n = 5). Variceal bleeding occurred at 27 months (4 to 72 months) and portal stenting was performed at 37 months (4 to 121 months), on average, postoperatively. Technical success, treatment efficacy, and clinical success rates were 90.9, 100, and 81.8%, respectively. The primary patency rate of portal stent was 88.9% during the mean follow-up period of 9 months. Neither procedure-related complication nor mortality occurred. CONCLUSION: Interventional portal stenting is an effective treatment for delayed jejunal variceal bleeding due to portal occlusion after hepatobiliary-pancreatic surgery.
Biliary Atresia
;
Child
;
Esophageal and Gastric Varices
;
Follow-Up Studies
;
Hemorrhage*
;
Humans
;
Liver Transplantation
;
Male
;
Methods
;
Mortality
;
Portal Vein*
;
Recurrence
;
Stents*
;
Treatment Outcome
;
Varicose Veins*
6.Comparison of the accuracy of neutrophil CD64 and C-reactive protein as a single test for the early detection of neonatal sepsis.
Young Kwang CHOO ; Hyun Seok CHO ; In Bum SEO ; Hyeon Soo LEE
Korean Journal of Pediatrics 2012;55(1):11-17
PURPOSE: Early identification of neonatal sepsis is a global issue because of limitations in diagnostic procedures. The objective of this study was to compare the diagnostic accuracy of neutrophil CD64 and C-reactive protein (CRP) as a single test for the early detection of neonatal sepsis. METHODS: A prospective study enrolled newborns with documented sepsis (n=11), clinical sepsis (n=12) and control newborns (n=14). CRP, neutrophil CD64, complete blood counts and blood culture were taken at the time of the suspected sepsis for the documented or clinical group and at the time of venipuncture for laboratory tests in control newborns. Neutrophil CD64 was analyzed by flow cytometry. RESULTS: CD64 was significantly elevated in the groups with documented or clinical sepsis, whereas CRP was not significantly increased compared with controls. For documented sepsis, CD64 and CRP had a sensitivity of 91% and 9%, a specificity of 83% and 83%, a positive predictive value of 83% and 33% and a negative predictive value of 91% and 50%, respectively, with a cutoff value of 3.0 mg/dL for CD64 and 1.0 mg/dL for CRP. The area under the receiver-operating characteristic curves for CD64 index and CRP were 0.955 and 0.527 (P<0.01), respectively. CONCLUSION: These preliminary data show that diagnostic accuracy of CD64 is superior to CRP when measured at the time of suspected sepsis, which implies that CD64 is a more reliable marker for the early identification of neonatal sepsis as a single determination compared with CRP.
Blood Cell Count
;
C-Reactive Protein
;
Humans
;
Infant, Newborn
;
Neutrophils
;
Phlebotomy
;
Prospective Studies
;
Sensitivity and Specificity
;
Sepsis
7.Congenital Hemangiopericytoma in the Retroperitoneum: A Case Report in a Newborn.
Young Kwang CHOO ; Hyun Seok CHO ; Suk Bae MOON ; Gu KANG ; Hyeon Soo LEE
Korean Journal of Perinatology 2011;22(4):362-366
Hemangiopericytoma is a rare vascular tumor that usually occurs in adults. The tumor is believed to originate from pericytes that are closely related to the capillary walls. Congenital hemangiopericytoma is a more rare disease that occurs in approximately 0.03% of all heamngiopericytomas. Herein, we describe a 1-month-old male newborn with huge congenital hemangiopericytoma in the retroperitoneum that exhibited a typical morphological vascular pattern.
Adult
;
Capillaries
;
Hemangiopericytoma
;
Humans
;
Infant, Newborn
;
Male
;
Pericytes
;
Rare Diseases
8.A Case of Ovarian Fibrosarcoma.
Hyun Jung KWON ; Ook Jin CHOO ; Bo Young BANG ; Kwang Yeob CHOI ; Yu Duk CHOI
Korean Journal of Obstetrics and Gynecology 1997;40(5):1097-1101
Fibromatous tumors of the ovary are considered to originate from specialized ovarianstromal cells and account for approximately 4% of all ovarian neoplasms. Most ovarianfibromatous tumors are benign, but infrequently there are histologically malignant appearances.Malignant fibromatous tumor can be categorized into two separate types of tumorsrelating to prognosis, cellular fibroma and fibrosarcoma. The cellular fibroma has one tothree mitotic counts per 10 high power fields(HPF). Unless an adhesion or rupture appearson this tumor, recurrence should not happen after operation. Furthermore, where themitotic count per 10 HPF is over four, it is classified as a very bad fibrosarcoma case interms of prognosis.We have met a case of large ovarian fibrosarcoma with has ten mitotic counts per10 HPF. We hereby report this case with the brief review of literatures.
Female
;
Fibroma
;
Fibrosarcoma*
;
Ovarian Neoplasms
;
Ovary
;
Prognosis
;
Recurrence
;
Rupture
9.Transient carnitine transport defect with cholestatic jaundice: report of one case in a premature baby.
Hyun Seok CHO ; Young Kwang CHOO ; Hong Jin LEE ; Hyeon Soo LEE
Korean Journal of Pediatrics 2012;55(2):58-62
Carnitine (beta-hydroxy-gamma-trimethylaminobutyric acid) is involved in the transport of long-chain fatty acids into the mitochondrial matrix and the removal of potentially toxic acylcarnitine esters. Transient carnitine transport defect is a rare condition in newborns reported in 1/90,000 live births. In this paper, we describe a case of transient carnitine transport defect found in a premature baby who had prolonged cholestatic jaundice and poor weight gain, and who responded dramatically to oral carnitine supplementation.
Carnitine
;
Esters
;
Fatty Acids
;
Humans
;
Infant, Newborn
;
Jaundice, Obstructive
;
Live Birth
;
Weight Gain
10.Transient carnitine transport defect with cholestatic jaundice: report of one case in a premature baby.
Hyun Seok CHO ; Young Kwang CHOO ; Hong Jin LEE ; Hyeon Soo LEE
Korean Journal of Pediatrics 2012;55(2):58-62
Carnitine (beta-hydroxy-gamma-trimethylaminobutyric acid) is involved in the transport of long-chain fatty acids into the mitochondrial matrix and the removal of potentially toxic acylcarnitine esters. Transient carnitine transport defect is a rare condition in newborns reported in 1/90,000 live births. In this paper, we describe a case of transient carnitine transport defect found in a premature baby who had prolonged cholestatic jaundice and poor weight gain, and who responded dramatically to oral carnitine supplementation.
Carnitine
;
Esters
;
Fatty Acids
;
Humans
;
Infant, Newborn
;
Jaundice, Obstructive
;
Live Birth
;
Weight Gain